These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23934511)

  • 21. Late relapse in primary central nervous system lymphoma: clonal persistence.
    Nayak L; Hedvat C; Rosenblum MK; Abrey LE; DeAngelis LM
    Neuro Oncol; 2011 May; 13(5):525-9. PubMed ID: 21372070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and challenges in the treatment of primary central nervous system lymphoma.
    Yang H; Xun Y; Yang A; Liu F; You H
    J Cell Physiol; 2020 Dec; 235(12):9143-9165. PubMed ID: 32420657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of primary central nervous system lymphoma].
    Gonzalez-Aguilar A; Houillier C; Soussain C; Hoang-Xuan K
    Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
    Tyson RM; Siegal T; Doolittle ND; Lacy C; Kraemer DF; Neutwelt EA
    Leuk Lymphoma; 2003 Apr; 44(4):627-33. PubMed ID: 12769339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of autologous stem cell transplantation in primary central nervous system lymphoma.
    Ferreri AJ; Illerhaus G
    Blood; 2016 Mar; 127(13):1642-9. PubMed ID: 26834241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma.
    Steffanoni S; Calimeri T; Anzalone N; Mastaglio S; Bernardi M; Ferreri AJ
    Expert Rev Hematol; 2022 Jan; 15(1):33-43. PubMed ID: 34904506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma.
    Blasco H; Senecal D; Le Gouge A; Pinard E; Benz-de Bretagne I; Colombat P; Hulot JS; Chatelut E; Le Guellec C
    Br J Clin Pharmacol; 2010 Sep; 70(3):367-75. PubMed ID: 20716237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5. Report on workshop: Primary CNS lymphoma.
    Korfel A; Finke J; Schmidt-Wolf I; Thiel E
    Ann Hematol; 2001; 80 Suppl 3():B20-3. PubMed ID: 11757699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients.
    Jalaeikhoo H; Yekaninejad MS; Hajizamani S; Rahim F; Ahmadzadeh A; Keyhani M; Sadeghi Hariri B; Saki N
    Arch Iran Med; 2015 Sep; 18(9):577-81. PubMed ID: 26317598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.
    Ponzoni M; Issa S; Batchelor TT; Rubenstein JL
    Ann Oncol; 2014 Feb; 25(2):316-22. PubMed ID: 24265352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma.
    Cho H; Chang JH; Kim YR; Kim SJ; Chung H; Park H; Lee JY; Jang JE; Kim Y; Kim SH; Yang WI; Suh CO; Cheong JW; Min YH; Kim JS
    Br J Haematol; 2016 Aug; 174(3):444-53. PubMed ID: 27018207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma.
    Miyao K; Sakemura R; Imai K; Sakai T; Tsushita N; Kato T; Niimi K; Ono Y; Sawa M
    Int J Hematol; 2014 Aug; 100(2):152-8. PubMed ID: 24947495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T; Fukushima T
    J Neurooncol; 2003 May; 63(1):87-95. PubMed ID: 12814260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
    Omuro A; Correa DD; DeAngelis LM; Moskowitz CH; Matasar MJ; Kaley TJ; Gavrilovic IT; Nolan C; Pentsova E; Grommes CC; Panageas KS; Baser RE; Faivre G; Abrey LE; Sauter CS
    Blood; 2015 Feb; 125(9):1403-10. PubMed ID: 25568347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Primary Central Nervous System Lymphoma.
    Patrick LB; Mohile NA
    Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
    Khan RB; Shi W; Thaler HT; DeAngelis LM; Abrey LE
    J Neurooncol; 2002 Jun; 58(2):175-8. PubMed ID: 12164690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment approaches for primary CNS lymphomas.
    Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
    Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.